CVRx (CVRX) Competitors $12.31 +0.13 (+1.06%) As of 03:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CVRX vs. LQDA, BLFS, MDXG, FNA, PLSE, ESTA, RXST, AORT, EYE, and EMBCShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include Liquidia (LQDA), BioLife Solutions (BLFS), MiMedx Group (MDXG), Paragon 28 (FNA), Pulse Biosciences (PLSE), Establishment Labs (ESTA), RxSight (RXST), Artivion (AORT), National Vision (EYE), and Embecta (EMBC). These companies are all part of the "medical equipment" industry. CVRx vs. Liquidia BioLife Solutions MiMedx Group Paragon 28 Pulse Biosciences Establishment Labs RxSight Artivion National Vision Embecta CVRx (NASDAQ:CVRX) and Liquidia (NASDAQ:LQDA) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, community ranking, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership. Is CVRX or LQDA more profitable? CVRx has a net margin of -116.91% compared to Liquidia's net margin of -765.38%. CVRx's return on equity of -93.06% beat Liquidia's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-116.91% -93.06% -51.78% Liquidia -765.38%-163.21%-67.14% Which has more risk & volatility, CVRX or LQDA? CVRx has a beta of 1.34, indicating that its share price is 34% more volatile than the S&P 500. Comparatively, Liquidia has a beta of 0.07, indicating that its share price is 93% less volatile than the S&P 500. Do institutionals and insiders hold more shares of CVRX or LQDA? 75.3% of CVRx shares are held by institutional investors. Comparatively, 64.5% of Liquidia shares are held by institutional investors. 18.9% of CVRx shares are held by company insiders. Comparatively, 30.1% of Liquidia shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in CVRX or LQDA? Liquidia received 172 more outperform votes than CVRx when rated by MarketBeat users. However, 73.33% of users gave CVRx an outperform vote while only 68.56% of users gave Liquidia an outperform vote. CompanyUnderperformOutperformCVRxOutperform Votes3373.33% Underperform Votes1226.67% LiquidiaOutperform Votes20568.56% Underperform Votes9431.44% Which has better valuation & earnings, CVRX or LQDA? CVRx has higher revenue and earnings than Liquidia. Liquidia is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$51.29M6.25-$59.97M-$2.69-4.58Liquidia$15.61M83.55-$78.50M-$1.63-9.45 Do analysts rate CVRX or LQDA? CVRx presently has a consensus price target of $17.83, indicating a potential upside of 44.88%. Liquidia has a consensus price target of $26.63, indicating a potential upside of 72.78%. Given Liquidia's stronger consensus rating and higher possible upside, analysts clearly believe Liquidia is more favorable than CVRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86Liquidia 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.11 Does the media refer more to CVRX or LQDA? In the previous week, Liquidia had 13 more articles in the media than CVRx. MarketBeat recorded 14 mentions for Liquidia and 1 mentions for CVRx. CVRx's average media sentiment score of 1.11 beat Liquidia's score of -0.12 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Liquidia 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral SummaryCVRx beats Liquidia on 10 of the 18 factors compared between the two stocks. Remove Ads Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$320.50M$4.48B$5.73B$8.07BDividend YieldN/A29.39%4.41%4.08%P/E Ratio-4.5829.6024.2418.96Price / Sales6.2551.18399.1689.65Price / CashN/A51.0838.1134.64Price / Book4.516.276.904.35Net Income-$59.97M$67.64M$3.19B$246.92M7 Day Performance11.39%9.70%2.14%3.16%1 Month Performance-12.14%-4.32%0.54%-8.03%1 Year Performance-41.08%23.29%14.17%3.56% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx2.2235 of 5 stars$12.31+1.1%$17.83+44.9%-41.1%$320.50M$51.29M-4.58160News CoveragePositive NewsLQDALiquidia2.3377 of 5 stars$13.83-6.7%$25.38+83.5%-6.9%$1.17B$15.61M-8.4850Earnings ReportAnalyst ForecastNews CoverageHigh Trading VolumeBLFSBioLife Solutions1.4284 of 5 stars$24.86-3.8%$29.86+20.1%+44.4%$1.17B$82.25M-23.45440Analyst UpgradeInsider TradeGap DownMDXGMiMedx Group3.3663 of 5 stars$7.79-1.3%$12.00+54.0%+0.5%$1.15B$348.88M14.16870FNAParagon 281.6105 of 5 stars$13.02-0.1%$14.20+9.1%+34.8%$1.09B$245.00M-17.59343,000Short Interest ↓News CoveragePLSEPulse Biosciences0.6377 of 5 stars$17.25-0.7%N/A+79.8%$1.06B$700,000.000.00140Upcoming EarningsESTAEstablishment Labs2.3084 of 5 stars$36.69-12.0%$57.40+56.4%-20.9%$1.06B$166.03M-14.22960High Trading VolumeRXSTRxSight2.7395 of 5 stars$24.76-1.4%$51.63+108.5%-49.3%$1.00B$139.93M-29.83220Analyst ForecastAORTArtivion3.7126 of 5 stars$23.59-2.4%$31.40+33.1%+19.6%$991.87M$388.54M-1,179.451,500Gap DownHigh Trading VolumeEYENational Vision1.2557 of 5 stars$11.67-4.0%$14.00+20.0%-44.2%$919.40M$1.82B-58.3513,998EMBCEmbecta4.6093 of 5 stars$13.96+9.5%$23.00+64.8%+6.1%$811.55M$1.11B13.962,100News CoveragePositive NewsHigh Trading Volume Remove Ads Related Companies and Tools Related Companies LQDA Competitors BLFS Competitors MDXG Competitors FNA Competitors PLSE Competitors ESTA Competitors RXST Competitors AORT Competitors EYE Competitors EMBC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CVRX) was last updated on 3/20/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored2025 Market CrashThe same data indicates we WILL likely see a market crash during President Trump's second year in office - 202...Chaikin Analytics | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
